Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Maria Aspan, Kinsey Crowley

U.S. women need better birth control. So why is this contraceptive company 'on life support?'

Saundra Pelletier, CEO of Evofem Biosciences. (Credit: Photograph by Jessica Pons for Fortune)

Good morning, Broadsheet readers! Fortune's Best Companies to Work For list features two women-led companies in the top 10, the Biden administration is investing in repurposing coal mines, and Fortune's Maria Aspan reports on the big business problems for birth control companies. Have a great day!

- Birth control fail. Ten years ago, Saundra Pelletier joined what became Evofem Biosciences, a small pharma company focusing on women’s health. A passionate, tireless CEO—and a savvy, feminist marketer—Pelletier spent the next seven years in expensive regulatory limbo, fighting for FDA approval for Evofem’s first and only product. Finally, in 2020, Evofem was able to launch that drug, a nonhormonal contraceptive gel called Phexxi. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.